From: Triple negative breast carcinoma is a prognostic factor in Taiwanese women
Features | DFS | Overall Survival | ||||
---|---|---|---|---|---|---|
 | HR | 95%CI | p-Value | HR | 95%CI | p-Value |
Age | 1.00 | 0.98–1.01 | 0.9058 | 1.04 | 1.01–1.06 | 0.0013 |
Tumor size, cm | 1.19 | 1.10–1.28 | <0.0001 | 1.17 | 1.04–1.32 | 0.0110 |
Lymph node | Â | Â | Â | Â | Â | Â |
   (Positive vs. Negative) | 2.65 | 1.79–3.92 | <0.0001 | 2.36 | 1.35–4.12 | 0.0026 |
Metastasis | Â | Â | Â | Â | Â | Â |
   (Yes vs. No) | 2.30 | 1.15–4.64 | 0.0193 | 6.63 | 3.13–14.09 | <0.0001 |
Grade | Â | Â | Â | Â | Â | Â |
   (III vs. I ~II) | 1.54 | 1.05–2.26 | 0.0269 | 2.11 | 1.23–3.62 | 0.0065 |
Tumor subgroups | Â | Â | Â | Â | Â | Â |
   (TNBC vs. non-TNBC) | 1.28 | 0.82–1.99 | 0.2835 | 1.66 | 0.93–2.96 | 0.0881 |
Node-positive | ||||||
Age | 0.99 | 0.97–1.01 | 0.2960 | 1.04 | 1.01–1.07 | 0.0161 |
Tumor size, cm | 1.23 | 1.10–1.37 | 0.0002 | 1.29 | 1.11–1.51 | 0.0011 |
Metastasis | Â | Â | Â | Â | Â | Â |
   (Yes vs. No) | 2.37 | 1.15–4.88 | 0.0198 | 7.52 | 3.37–16.79 | <0.0001 |
Grade | Â | Â | Â | Â | Â | Â |
   (III vs. I ~II) | 1.49 | 0.93–2.36 | 0.0948 | 2.46 | 1.23–4.90 | 0.0109 |
Tumor subgroups | Â | Â | Â | Â | Â | Â |
   (TNBC vs. non-TNBC) | 1.13 | 0.63–2.03 | 0.6847 | 2.20 | 1.08–4.49 | 0.0296 |
Node-negative | ||||||
Age | 1.02 | 0.99–1.04 | 0.1801 | 1.04 | 1.01–1.07 | 0.0186 |
Tumor size, cm | 1.16 | 1.02–1.31 | 0.0236 | 1.00 | 0.74–1.36 | 0.9813 |
Metastasis* | Â | Â | Â | Â | Â | Â |
   (Yes vs. No) | - | - | - | - | - | - |
Grade | Â | Â | Â | Â | Â | Â |
   (III vs. I ~ II) | 1.49 | 0.75–2.94 | 0.2526 | 1.69 | 0.69–4.12 | 0.2525 |
Tumor subgroups | Â | Â | Â | Â | Â | Â |
   (TNBC vs. non-TNBC) | 1.52 | 0.75–3.06 | 0.2461 | 1.28 | 0.47–3.19 | 0.6815 |